FSTL1 and nasopharyngeal carcinoma: Moreover, in nasopharyngeal carcinoma, FSTL1 blocks Wnt7a inhibition of ERK phosphorylation, inducing MMP9 production, extracellular matrix degradation, and metastasis [39].